Reversing fibrosis: New research provides insight for novel therapies

Yale School of Medicine (YSM) researchers have made key breakthroughs in understanding how to treat fibrotic diseases such as scleroderma and graft-versus-host disease.

Mesoblast and BMT CTN to Initiate Pivotal Trial of Ryoncil® as Part of First-Line Regimen in Adults with Severe Acute GVHD Refractory to Steroids

Dr John Levine, Chair of the BMT CTN Steering Committee and Professor of Internal Medicine and Pediatrics, Icahn School of Medicine at Mount Sinai, New York said: “We are delighted to be partnering ...
News-Medical.Net on MSN

Study demonstrates a safer strategy for allogeneic stem cell transplants

In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell transplant boosted survival, protected vital organs, and promoted a balanced gut ...

New protocol for Treg expansion uses targeted immunotherapy to reduce transplant complications

In preclinical studies, researchers found that priming the immune system with a Treg-expanding therapy before stem cell ...
Fred Hutch

Novel drug regimen reduces risks of graft-versus-host disease

Picture this: you’re surviving cancer, chemotherapy, radiation, immunosuppression, and a blood stem cell transplant, and you haven’t left the hospital in weeks. Yet, somehow, you have what feels and ...
Morningstar

CAGE Bio Announces Collaboration to Advance First-in-Class Treatments for Cutaneous Graft versus Host Disease

SAN CARLOS, Calif. and DALLAS, Aug. 27, 2025 /PRNewswire/ -- CAGE Bio Inc., a leader in advancing innovative therapies for targeted and localized treatment of immunological skin diseases, today ...
TMZ on MSN

Jimmy Kimmel's Band Leader Cleto Escobedo III Cause of Death Released

Jimmy Kimmel’s longtime bandleader, Cleto Escobedo III, died because his heart couldn't pump enough blood to keep him alive, TMZ has learned. The document also says other conditions that contributed ...